The International Antiviral Society–USA commissions volunteer panels of experts to develop clinical practice recommendations and guidelines in areas of antiviral medicine that are confusing or controversial. Funding for the guidelines is provided by the IAS–USA; commercial support is not accepted. Expert panel members participate on a volunteer basis.
Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance
Wensing AM, Charpentier C, Calvez V, et al. Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. Clin Infect Dis. 2025; https://doi.org/10.1093/cid/ciaf161. [epublished online April 3, 2025]
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel
Gandhi RT, Landovitz RJ, Sax PE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA Panel. JAMA. 2024; doi:10.1001/jama.2024.24543. [epublished online December 1, 2024]